“…The disruption of mitochondrial homeostasis is associated with several pathologies, such as neurodegeneration, cancer, aging, and cardiovascular diseases (Chen et al, 2023; Norat et al, 2020; Quirós et al, 2016; Suomalainen and Battersby, 2018). The UPRmt is an evolutionarily conserved homeostatic pathway engaged upon a wide range of mitochondrial insults, including mitochondrial protein misfolding (Zhao et al, 2002), reduced mitochondrial protein import efficiency (Nargund et al, 2012), dissipation of mitochondrial membrane potential (Donehower et al, 2019), and dysregulated levels of reactive oxygen species (ROS) (Wang et al, 2022b). UPRmt activation triggers a broad and protective transcriptional cascade, through enhancing mitochondrial folding capacity and triggering a mitochondrial recovery program, alleviating neurodegenerative and cardiovascular diseases symptomatology (Smyrnias et al, 2019; Sorrentino et al, 2017), promoting resistance to pathogen infection (Mahmud et al, 2020; Pellegrino et al, 2014), and prolonging lifespan (Munkácsy and Rea, 2014).…”